These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6455787

  • 1. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC.
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC, Drusano GL, McNamee WB, Tatem B, Ryan PA, Schimpff SC.
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.
    Neu HC, Aswapokee P, Fu KP, Ho I, Matthijssen C.
    Clin Pharmacol Ther; 1980 May; 27(5):677-85. PubMed ID: 6245831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [Abstract] [Full Text] [Related]

  • 9. Moxalactam--absorption, excretion, distribution, and metabolism.
    Shimada J, Ueda Y.
    Rev Infect Dis; 1982 May; 4 Suppl():S569-80. PubMed ID: 6218568
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of cefotaxime.
    Fu KP, Aswapokee P, Ho I, Matthijssen C, Neu HC.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [Abstract] [Full Text] [Related]

  • 11. Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.
    Boscia JA, Korzeniowski OM, Snepar R, Kobasa WD, Levison ME, Kaye D.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):385-9. PubMed ID: 6221691
    [Abstract] [Full Text] [Related]

  • 12. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B, Lode H, Belmega G, Jendroschek T, Borner K, Koeppe P.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [Abstract] [Full Text] [Related]

  • 13. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K, Adam D.
    Arzneimittelforschung; 1981 Mar; 31(10):1770-2. PubMed ID: 6459099
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of cefoperazone after single and multiple doses.
    Ripa S, La Rosa F, Dainelli B, Ecari U, Ruffilli MP.
    Int J Clin Pharmacol Res; 1986 Mar; 6(2):171-5. PubMed ID: 3721648
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of cefoperazone in patients with neoplastic disease.
    Maksymiuk AW, LeBlanc BM, Brown NS, Ho DH, Bodey GP.
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1037-41. PubMed ID: 6455966
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC, Srinivasan S.
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ceforanide kinetics.
    Estey EH, Weaver SS, LeBlanc BM, Brown N, Ho DH, Bodey GP.
    Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL, Hatheway GJ, Gambertoglio JG, Lin ET, Conte JE.
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.